Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SOTALOL | 160MG | TABLET | Resolved | 2023-12-08 | 2024-01-05 | 212952 |
| APO-SOTALOL | 160MG | TABLET | Resolved | 2024-01-12 | 2024-01-19 | 215976 |
| APO-SOTALOL - TAB 160MG | 160MG | TABLET | Resolved | 2017-10-12 | 2018-01-19 | 25636 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2017-09-04 | 2018-01-19 | 20906 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2022-05-06 | 2022-07-15 | 160141 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2020-11-19 | 2021-02-09 | 128626 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Resolved | 2018-07-04 | 2018-07-13 | 54187 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2017-09-06 | 2018-09-11 | 21096 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2020-01-22 | 2020-03-09 | 103923 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Actual shortage | 2025-02-06 | 2025-02-06 | 249763 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2022-09-09 | 2023-09-22 | 169045 |
| APO-SULFATRIM ORAL SUSPENSION | 40MG 8MG | SUSPENSION | Actual shortage | 2017-08-13 | 2017-10-05 | 18991 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2017-06-28 | 2017-08-30 | 14247 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-10-08 | 2021-12-22 | 146913 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2018-04-02 | 2018-11-02 | 44517 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2018-04-10 | 2018-11-03 | 45350 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-01-18 | 2021-02-05 | 131889 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2023-07-21 | 2023-09-15 | 199539 |
| APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2023-12-01 | 2023-12-15 | 212380 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221732 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |